首页 | 本学科首页   官方微博 | 高级检索  
     

33例耐多药肺结核患者督导服药现状研究
引用本文:李文婧,孙强,边学峰,张加胜,陈诚,李仁忠. 33例耐多药肺结核患者督导服药现状研究[J]. 医学与哲学(人文社会医学版), 2011, 0(2): 35-36,38
作者姓名:李文婧  孙强  边学峰  张加胜  陈诚  李仁忠
作者单位:[1]山东大学卫生管理与政策研究中心,山东济南250012 [2]济南市疾病预防控制中心,山东济南250001 [3]中国疾病预防控制中心结核病预防控制中心,北京102206
基金项目:“艾滋病和病毒性肝炎等重大传染病防治”科技部重大专项结核病发病模式研究,项目编号:2008ZX10003007
摘    要:为了解耐多药肺结核患者督导服药情况,本文对33例耐多药肺结核患者与12名医务人员进行调查。结果显示,没有接受过直接面试下督导服药和访视的患者分别占40%和50%,患者确诊后的管理情况并没有比确诊前有明显好转。因此.要加大政府的投入力度,加强专科医院和结防机构之间的医防合作,从而强化对患者的服药管理。

关 键 词:耐多药肺结核  直接面视下服药  访视

Study on The Directly Observed Therapy of 33 MDR-- TB Patients
Affiliation:LI Wen-jing, SUN Qiang, BIAN Xue feng, et al.( Center for Health Management and Policy, Shandong University, Jinan 250012, China)
Abstract:To understand directly observed therapy of MDR--TB patients, 33 MDR--TB patients and 12 corresponding key persons were surveyed and in--depth interviewed. Result shows, 40% of patients did not receive directly observed therapy, 50% of patients did not receive any visits. Patients did not significantly improved compared with before the diagnosis. So the government must increase investment, the communication and cooperation between the special hospitals and TB spe cialist institutions need to be strengthened to enhance the medicine management of patients.
Keywords:MDR-- TB   directly observed therapy   visit
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号